US pauses J&J vaccine in blow to global immunisation drive


Health authorities in the US have paused administration of the Johnson & Johnson Covid-19 vaccine after six women between age 18 and 48 developed a rare type of blood clot in the brain. The drug company will also delay its European roll-out of the vaccine. – EPA pic, April 14, 2021.

US health authorities have recommended pausing the Johnson & Johnson Covid-19 shot over blood clot fears, with the company announcing it would delay its European roll-out in a setback for global immunisation efforts.

Out of nearly seven million Americans who have so far received the single-dose vaccine, six women between age 18 and 48 developed a rare type of clot in the brain, officials said.


Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!


Sign up or sign in here to comment.


Comments